
The Future of Microsurgery is Robotics and AI. Horizon Surgical Systems, founded in 2021 by experts in ophthalmology and medical robotics, is at the forefront of innovation in microsurgery. Our groundbreaking product, Polaris, leverages state-of-the-art robotics, advanced medical imaging, and AI to extend the capabilities of surgeons beyond their current limitations. With a foundation rooted in academic excellence and a vision for the future, Horizon is committed to revolutionize global healthcare through technological innovation, bringing a new era of precision, enhanced outcomes, and safety to eye care.

The Future of Microsurgery is Robotics and AI. Horizon Surgical Systems, founded in 2021 by experts in ophthalmology and medical robotics, is at the forefront of innovation in microsurgery. Our groundbreaking product, Polaris, leverages state-of-the-art robotics, advanced medical imaging, and AI to extend the capabilities of surgeons beyond their current limitations. With a foundation rooted in academic excellence and a vision for the future, Horizon is committed to revolutionize global healthcare through technological innovation, bringing a new era of precision, enhanced outcomes, and safety to eye care.
Product: Polaris — AI-supported, imaging-guided micro-robotic platform for ophthalmic microsurgery (investigational)
Founded: 2021
Headcount: 62 employees
Funding: $30M Series A (Oct 2024), total funding reported $30M
Origin: Spun out of UCLA (Stein Eye Institute and Henry Samueli School of Engineering)
Ophthalmic microsurgery; improving precision, safety, and outcomes in eye surgery.
2021
Medical Equipment Manufacturing
$30,000,000
Participation reported from UC Investments and Main Street Advisors; announced by the company.
“Lead investor: ExSight Ventures; participation from UC Investments and Main Street Advisors”
| Company |
|---|